WHO-India Relations: Historical Context and Evolution
The World Health Organization established its South-East Asia Regional Office (SEARO) in Delhi in 1948, making India a founding member with significant influence in global health governance. India's relationship with WHO has evolved from recipient nation to leader in health innovations, particularly post-independence. The country contributes substantially to WHO's budget and expertise, hosting crucial initiatives like the Global Advisory Committee on Vaccine Safety and polio eradication programs. India's G20 presidency in 2023 elevated health on the international agenda, advocating for pandemic preparedness reforms. The WHO has recognized India's achievements in vaccination drives, maternal mortality reduction (MMR declined from 212 to 97 per 100,000 live births between 2005-2019), and disease surveillance systems. This partnership demonstrates India's commitment to Universal Health Coverage (UHC) and strengthening health systems across the Global South.
COVID-19 Pandemic Response and India's Leadership Role
India's COVID-19 response showcased collaborative governance with WHO while advocating for equitable vaccine distribution. The country administered over 2.2 billion vaccine doses, becoming the world's largest vaccination program by volume. India criticized WHO's initial vaccine equity stance and championed COVAX (COVID-19 Vaccines Global Access), though tensions emerged regarding vaccine nationalism and intellectual property rights. The government established the National Task Force and COVID-19 Working Group, coordinating with international bodies while prioritizing domestic resilience. India's manufacturing capacity proved invaluable—producing vaccines for 100+ countries, addressing the 'Vaccine Apartheid' concern raised by India and South Africa. The pandemic exposed gaps in surveillance systems, prompting India to strengthen its Integrated Disease Surveillance Programme (IDSP) with enhanced real-time data collection. Post-pandemic, India advocated for WHO reforms ensuring equitable resource distribution and prioritizing developing nations' healthcare infrastructure needs.
Universal Health Coverage: India's UHC Mission and WHO Support
Ayushman Bharat (AB) launched in 2018 as India's flagship UHC scheme, aiming to provide health insurance to 500 million individuals, receiving WHO commendation for innovative design. The scheme combines two components: Pradhan Mantri Jan Arogya Yojana (PM-JAY) for hospital insurance and Health and Wellness Centers (HWCs) for primary care. WHO recognizes AB as a transformative step toward SDG 3 (Good Health and Well-being), particularly in rural areas where healthcare access remained critical. The program covers 10,000 co-morbidities, reducing out-of-pocket expenditure—a key WHO metric for UHC progress. India's health spending increased from 3.2% GDP (2017) to targeted 5% by 2025, aligning with WHO recommendations. However, challenges persist: rural doctor shortages, infrastructure gaps, and implementation disparities across states. WHO's technical support through capacity-building programs and evidence-based policy recommendations strengthens AB's execution. India's UHC journey provides a replicable model for middle-income countries, demonstrating how centralized health schemes can achieve equity while maintaining fiscal sustainability.
Health System Strengthening and Reform Advocacy
India's health system reforms address critical governance gaps while advocating for WHO structural changes reflecting developing nations' perspectives. The National Health Mission (NHM), operational since 2013, emphasizes decentralization, community participation, and disease surveillance strengthening. India champions reform in WHO's governance structure, advocating for increased representation of Global South nations in decision-making bodies and technical committees. The country has successfully advocated for WHO amendments supporting traditional medicine integration—reflected in the 2022 World Health Assembly recognition of Traditional and Complementary Medicine. India's proposal for pandemic preparedness included establishing regional centers for disease surveillance and manufacturing hubs, addressing supply chain vulnerabilities exposed by COVID-19. The government strengthened the Public Health Foundation of India (PHFI) and established the Indian Council of Medical Research (ICMR) as autonomous bodies for research translation. India's advocacy demonstrates how developing nations can influence global health norms while simultaneously implementing domestic reforms addressing infectious and non-communicable disease burdens.
Pandemic Preparedness and One Health Approach Implementation
India's strategic advocacy for pandemic preparedness emphasizes the One Health approach—integrating human, animal, and environmental health sectors. The country established the National Center for Disease Control (NCDC) as WHO's collaborating center for priority pathogens and emerging infectious diseases. India's animal health sector, managed by the Department of Animal Husbandry, increasingly coordinates with human health authorities through inter-ministerial task forces addressing zoonotic diseases. The 2023 Bird Flu outbreak response demonstrated improved surveillance through rapid reporting to WHO and coordinated culling protocols. India advocated for the Pandemic Prevention, Preparedness, and Response (PPPR) agreement during the 2023 World Health Assembly, emphasizing equitable access to countermeasures and technology transfer provisions. Establishment of India Biosafety Organization enhances laboratory standards aligned with WHO guidelines. The country's proposal for Regional Disaster Management Authorities strengthens health emergency responses. India's One Health initiatives particularly address antimicrobial resistance (AMR)—a WHO priority—through the National Action Plan on AMR involving agriculture, veterinary, and human health sectors.
Key Challenges and Reform Advocacy Areas
Despite collaboration successes, India-WHO relations face tensions regarding health sovereignty and policy preferences. India contests WHO's funding mechanisms, noting disproportionate burden-sharing among developing nations while wealthier countries receive subsidized technical support. The 2022 monkeypox emergency highlighted vaccine access disparities—India argued for technology transfer and local manufacturing rights rather than dependency on limited global supplies. Tobacco control presents another contentious area; while India supports WHO Framework Convention on Tobacco Control, implementation faces resistance from agricultural lobbies. Mental health and non-communicable disease management remain underfunded despite WHO recommendations. India advocates for WHO's recognition of indigenous healthcare systems, though standardization protocols remain under negotiation. The country champions reforms in pharmaceutical pricing governance and equitable drug access through WHO mechanisms. India's advocacy emphasizes that health security cannot be achieved through top-down guidelines alone—domestic contextual implementation, financial autonomy, and respecting health sovereignty are essential prerequisites for achieving collective health goals.